LexaGene Holdings Inc. (CVE:LXG – Get Free Report) shares were down 19.2% during mid-day trading on Friday . The stock traded as low as C$0.10 and last traded at C$0.11. Approximately 2,135,377 shares traded hands during trading, an increase of 1,156% from the average daily volume of 170,061 shares. The stock had previously closed at C$0.13.
LexaGene Stock Down 19.2 %
The company has a current ratio of 1.39, a quick ratio of 1.13 and a debt-to-equity ratio of 138.01. The firm has a market cap of C$14.77 million, a price-to-earnings ratio of -1.31 and a beta of 2.26. The firm has a 50-day moving average of C$0.11 and a two-hundred day moving average of C$0.11.
About LexaGene
LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
Featured Articles
- Five stocks we like better than LexaGene
- How to Calculate Return on Investment (ROI)
- 52-week Low Names To Tip The Upside Scale In Your Favor
- How to Invest in Lithium and Lithium Stocks
- KB Home Price Weakness is a Signal to Buy this Cash Machine
- High Flyers: 3 Natural Gas Stocks for March 2022
- Analysts Went All In On These Computer Stocks, Save Your Spot
Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.
